Talat Imran
Chief Executive Officer, Ronnie Therapeutics
Replay available
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) Q4 2025 earnings conference call, held 2026-03-26. Replay captured from the company's public earnings webcast.

Chief Executive Officer, Ronnie Therapeutics
Chief Financial Officer, Ronnie Therapeutics
Analyst, Maximum Group
Analyst, HC William Wright
Gilmartin Group
Watch the replay and follow the connected company analysis, news, and investor updates for Rani Therapeutics Holdings, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.136 Welcome to the Rainey fourth quarter and full year 2025 financial results and 00:00:05.136 -- 00:00:09.780 corporate update conference call. At this time, all participants are on a listen-only 00:00:09.780 -- 00:00:15.486 mode. Following managers' prepared remarks, Rainey will hold a QA session. 00:00:15.486 -- 00:00:20.570 To ensure that you have ample time to address everyone's questions during the QA session, 00:00:20.570 -- 00:00:25.013 we will ask you to limit yourself to one question and one follow-up. 00:00:25.055 -- 00:00:30.220 To ask a question at that time, please press star 11 on your touchtone telephone. 00:00:30.220 -- 00:00:36.247 As a reminder, this call is being recorded today, March 26th, 2026. 00:00:36.247 -- 00:00:41.132 I would now like to turn the conference over to your speaker for today. 00:00:41.132 -- 00:00:46.857 Steven Jasper of Gilmartin Group, please go ahead. 00:00:51.044 -- 00:00:52.866 Thank you, Operator. 00:00:52.866 -- 00:00:57.351 Joining us on the call today from Ronnie Therapeutics are Chief Executive Officer Talat 00:00:57.351 -- 00:01:01.237 Imran and Chief Financial Officer Svye Sanford. 00:01:01.237 -- 00:01:05.182 Earlier today, Ronnie released financial results for the quarter and year-ended December 00:01:05.182 -- 00:01:07.442 31st, 2025. 00:01:07.544 -- 00:01:11.827 A copy of the press release is available on the company's website. 00:01:11.849 -- 00:01:15.754 During this conference call, management will make forward-looking statements that are 00:01:15.754 -- 00:01:20.919 subject to risks, uncertainties, and assumptions, such as, but not limited to 00:01:20.919 -- 00:01:25.465 those discussed in the risk factors section of the company's filings with the Securities 00:01:25.465 -- 00:...